Data management

SGS invests €3.5m in its French bioanalytical site

13-Dec-2018 By Maggie Lynch

This second phase of the two-phase expansion project will increase the company’s bioanalytical capabilities at the site by 50% when the expansion is complete in 2020.

Infographic: Unifying clinical operations

13-Dec-2018 By Melissa Fassbender

CROs are taking steps to improve study start-up as collaboration with sites and sponsors continues to be a challenge, one which a unified clinical operations model aims to address.

CROs lead adoption of purpose-built clinical applications: Report

13-Dec-2018 By Melissa Fassbender

CROs are upping investment in modern eClinical solutions – a market expected to reach beyond $13bn by 2024.

Biorasi closes PE deal, next stage to be ‘vastly different’ as CRO plans scale-up

13-Dec-2018 By Melissa Fassbender

Biorasi plans to scale several aspects of its global CRO business following a PE investment – and while it does not plan to “buy size,” smaller strategic acquisitions are not out of the question, says company executive.

AiCure’s client base sees uptick as the industry looks to reduce risk

12-Dec-2018 By Maggie Lynch

After a significant client increase, the behavioral data platform saw revenue growth that more than a doubled year-over-year from 2017.

Guest Column

Collaboration created the cornerstone of better clinical trials – now, it’s time to build

12-Dec-2018 By Pamela Tenaerts, executive director, Clinical Trials Transformation Initiative (CTTI)

We entered 2018 with a solid foundation in place for building better, more efficient clinical trials. Throughout the year, progress – particularly in the areas of mobile technologies, real-world evidence, and patient engagement – resulted in new, tangible...

The biggest paradigm shift in decades? ICH E6 R2

11-Dec-2018 By Melissa Fassbender

ICH E6 R2 sparked a paradigm shift, though 2019 will see the clinical trials industry transition from a risk-based monitoring approach to risk-based quality management.

More data will be generated in 2019 than in the last 5,000 years

11-Dec-2018 By Melissa Fassbender

The new year will bring more data than the last 500 decades, information that will be used to improve clinical trial design and shorten drug development timelines, say industry experts.

2018 brought record drug approvals, but 2019 needs to bring greater efficiency

11-Dec-2018 By Melissa Fassbender

The industry has a “tremendous opportunity” to build on its progress by further improving operational performance in the face of pricing and patient access challenges.

Clinerion adds 1.2m patients to network in Brazil

10-Dec-2018 By Maggie Lynch

Clinerion and Santa Casa da Misericordia hospital are partnering to bring clinical trial opportunities to patients and diverse data to CROs and sponsors.

Trialbee joins in on digital clinical solutions with patient-focused app

06-Dec-2018 By Maggie Lynch

The digital patient recruitment and engagement company has released its new digital solutions to build long-term relationships with clients, sponsors, and CROs.

Elsevier platform makes data ‘AI-ready’ to help researchers overcome R&D challenges

06-Dec-2018 By Melissa Fassbender

The information analytics business Elsevier has launched a new cloud-based data platform, Entellect, to de-silo, contextualize, and connect drug, target, and disease data.

Medidata collab sheds light on rare diseases, the value of precision medicine

06-Dec-2018 By Melissa Fassbender

Medidata’s machine learning-based solution revealed novel biomarkers for Castleman disease among other discoveries that could help accelerate diagnosis and treatment.

UK-funded study to investigate patients’ experience of cell and gene therapies

05-Dec-2018 By Flora Southey

Innovate UK is helping to fund the PROmics study, a programme designed to assess the effect of cell therapies on patient symptoms and quality of life.

Partnership will expand research into ‘urgently needed’ area

05-Dec-2018 By Maggie Lynch

SPARC and Schrödinger will collaborate to use Schrödinger’s technological platforms and SPARC’s insights into research therapeutics for neurodegenerative conditions.